A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader

挑战

Regulatory & linguistic complexity

Since 2010, QbD Group has partnered with this pharmaceutical leader to manage the intricate post-approval linguistic review process for a family of medicinal products. The complexity of coordinating multiple translations, ensuring alignment with QRD guidelines, and adhering to EMA procedures created significant challenges, including:

• Managing PI updates across 25 EU/EEA languages while meeting strict submission deadlines.
• Ensuring accuracy and consistency in translations across multiple regulatory frameworks.
• Implementing an efficient workflow to standardize processes and reduce errors.

Discover our approach

方法

Streamlining the linguistic review process

To ensure efficiency and accuracy, QbD Group developed a structured, standardized approach to translation management, quality control, and submission coordination. Our key strategies include:

• Early preparation of the English PI to align with QRD guidelines before MAA or post-approval submissions.
• Clear, well-defined processes supported by specialized software tools to ensure precision and consistency.
• A proactive workflow to meet strict regulatory deadlines without compromising quality.

Read more about the results

结果

Delivering regulatory excellence

With deep expertise in EMA procedures, QbD Group has successfully managed over 250 linguistic review procedures, ensuring:

• High-quality submissions that meet stringent regulatory requirements.
• Standardized processes and automation for enhanced accuracy and efficiency.
• A long-standing partnership built on trust, expertise, and proven results.

By combining regulatory know-how with an efficient, structured approach, QbD Group continues to support our client in maintaining compliance and ensuring clear, accurate product information across multiple markets.

Also need support?